Biotech earnings season continues with Horizon Pharma PLC (NASDAQ:HZNP) reporting fourth-quarter results on Monday, while Merrimack Pharmaceuticals Inc (NASDAQ:MACK) reported earnings yesterday after closing. Let’s …
Horizon Pharma PLC (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address …
Analyst Irina Rivkind Koffler of Mizuho Securities recently commented on the overall biotech industry, highlighting several companies. Among them were Valeant Pharmaceuticals Intl …
Horizon Pharma PLC (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that …
Analysts came out today with an optimistic view on biopharmaceutical giant Celgene Corporation (NASDAQ:CELG) and Irish pharmaceutical company Horizon Pharma PLC (NASDAQ:HZNP), as the iShares Nasdaq Biotechnology ETF …
Horizon Pharma PLC (NASDAQ:HZNP) is up close to 4% in pre-market trading after the company announced this morning that is adjusting its full …
Healthcare analysts at UBS and Brean Capital weighed in on the controversial drug giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and bio-pharmaceutical company Horizon Pharma PLC (NASDAQ:HZNP). The analysts …
Fitbit Inc (NYSE:FIT) shares are up nearly 4% in early Monday trading after Barclays analyst Matt McClintock upgraded the company from Equal Weight to Overweight, while …
